Phase 3 vascular outcomes study of ASA along with rivaroxaban in
endovascular or surgical limb revascularization for peripheral artery
disease (PAD) (Protocol BAY 59-7939/17454)
Please contact us for more information or to learn if you are eligible to participate.
